National Kidney Foundation. Chronic kidney Disease (CKD), The facts about chronic kidney disease (CKD), May 26, 2009, http://www.kidney.org/kidneydisease/ckd/index.cfm.
 N. Burrows, Y. Li, and D. Williams, “Racial and ethnic differences in trends of end stage renal disease: United States 1995 to 2005,” Advances in Chronic Kidney Disease, Vol. 15, No. 2, pp. 147–152.
 United Network for Organ Sharing, View Data Reports, National Data, Transplants by Donor Type, Kidney, May 25, 2009, http://optn.transplant.hrsa.gov/latestData/rptData.asp.
 E. Yen, et al., “Cost effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant,” American Journal of Transplantation, Vol. 4, No. 10, pp. 1703–1708, 2004.
 R. Saran, et al., “Longer treatment time and slower ultrafiltration in hemodialysis: Associations with reduced mortality in the DOPPS,” Kidney International, Vol. 69 No. 7, pp. 1222–1228, April 2006.
 United States Renal Data System Annual Data Report, Chapter 2, Incidence and Prevalence, 2008, http://www. USRDS.org.
 F. Coronel, et al., “Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis,” Journal of Nephrology, Vol. 16, No. 5, pp. 697–702, September–October, 2006.
 J. J. Snyder, R. N. Foley, D. T. Gilberston, E. F. Vonesh, and A. J. Collins, “Hemoglobin levels and erythropoietin doses in hemodialysis and peritoneal dialysis patients in the United States,” Journal of the American Society of Nephrology, Vol. 15, No. 1, pp. 174–179, 2004.
 United States Renal Data System Annual Data Report, Section K, The Economic Costs of ESRD, pp. 292, 2008, http://www.USRDS.org.